Earnings History Data for Veracyte, Inc. (VCYT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Veracyte, Inc.

Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
22-02-2024	AH		VCYT	Veracyte, Inc.	1,810	-0.04	-0.07	-0.05	Veracyte GAAP EPS of -$0.39 misses by $0.30, revenue of $98.2M beats by $5.42M [2/22/2024 4:32 PM]	22.17	-2.17 (-8.92%)	23.05	-1.29 (-5.30%)	19.52 - 30.52	706,327	640,000	143,821
Veracyte GAAP EPS of -$0.39 misses by $0.30, revenue of $98.2M beats by $5.42M [2/22/2024 4:32 PM]
07-11-2023	AH		VCYT	Veracyte, Inc.	1,780	-0.03	-0.16	-0.12	Veracyte GAAP EPS of -$0.41 misses by $0.26, revenue of $90.1M beats by $5.71M [11/7/2023 4:23 PM]	23.15	-0.86 (-3.58%)	25.23	1.22 (5.08%)	19.52 - 32.40	851,725	710,000	1,086
Veracyte GAAP EPS of -$0.41 misses by $0.26, revenue of $90.1M beats by $5.71M [11/7/2023 4:23 PM]
08-08-2023	AH		VCYT	Veracyte, Inc.	1,850	-0.12	-0.16	-0.13	Veracyte GAAP EPS of -$0.12 beats by $0.04, revenue of $90.32M beats by $7.23M [8/8/2023 4:43 PM]	26.71	1.71 (6.84%)	26.25	1.25 (5.00%)	14.92 - 32.40	773,115	600,000	1,118
Veracyte GAAP EPS of -$0.12 beats by $0.04, revenue of $90.32M beats by $7.23M [8/8/2023 4:43 PM]
04-05-2023	AH	4:05 PM ET (May 4)	VCYT	Veracyte, Inc.	1,510	-0.11	-0.14	-0.20	Veracyte GAAP EPS of -$0.11 beats by $0.03, revenue of $82.42M beats by $6.67M [5/4/2023 4:46 PM]	23.30	1.04 (4.68%)	22.26	0.0 (0.00%)	14.85 - 32.40	569,345	670,000	34,996
Veracyte GAAP EPS of -$0.11 beats by $0.03, revenue of $82.42M beats by $6.67M [5/4/2023 4:46 PM]
22-02-2023	AH	4:05 PM ET (Feb 22)	VCYT	Veracyte, Inc.	1,820	-0.05	-0.15	-0.15	Veracyte Q4 results beat estimates, co sees FY 2023 revenue guidance in-line [2/22/2023 4:36 PM]	23.90	0.0 (0.00%)	23.95	0.05 (0.21%)	14.85 - 32.40	880,392	780,000	1,112
Veracyte Q4 results beat estimates, co sees FY 2023 revenue guidance in-line [2/22/2023 4:36 PM]
02-11-2022	AH	4:05 PM ET (Nov 2)	VCYT	Veracyte, Inc.	1,440	-0.12	-0.24	-0.13	Veracyte GAAP EPS of -$0.12, revenue of $75.6M; raises FY outlook [11/2/2022 4:30 PM]	24.20	4.70 (24.08%)	22.65	3.15 (16.15%)	14.85 - 54.13	2,391,086	920,000	1,978
Veracyte GAAP EPS of -$0.12, revenue of $75.6M; raises FY outlook [11/2/2022 4:30 PM] Veracyte rises 10.6% after company raises full-year forecast [11/3/2022 8:53 AM] Veracyte (VCYT) Reports Q3 Loss, Tops Revenue Estimates [Nov-02-22 06:55PM] Veracyte Announces Third Quarter 2022 Financial Results [Nov-02-22 04:05PM]
02-08-2022	AH	4:05 PM ET (Aug 2)	VCYT	Veracyte, Inc.	1,750	-0.13	-0.21	-0.13	Veracyte GAAP EPS of -$0.13 beats by $0.10, revenue of $72.86M beats by $4.78M [8/2/2022 4:18 PM]	25.00	-1.64 (-6.16%)	27.00	0.36 (1.35%)	14.85 - 54.13	740,627	870,000	250
Veracyte GAAP EPS of -$0.13 beats by $0.10, revenue of $72.86M beats by $4.78M [8/2/2022 4:18 PM] Veracyte Announces Second Quarter 2022 Financial Results [Aug-02-22 04:05PM]
03-05-2022	AH	4:05 PM ET (May 3)	VCYT	Veracyte	1,525	-0.20	-0.23	0.00	Veracyte GAAP EPS of -$0.20 beats by $0.05, revenue of $67.78M beats by $5.86M [5/3/2022 4:15 PM]	22.41	0.95 (4.43%)	21.46	0.0 (0.00%)	20.04 - 54.13	1,899,622	1,060,000	24,288
Veracyte GAAP EPS of -$0.20 beats by $0.05, revenue of $67.78M beats by $5.86M [5/3/2022 4:15 PM] Envisia Genomic Classifier Highlighted in Updated Clinical Practice Guideline Regarding Idiopathic Pulmonary Fibrosis Diagnosis [May-02-22 04:18PM] Intellia Therapeutics Names Muna Bhanji, R.Ph., to its Board of Directors [May-02-22 04:01PM] Veracyte Announces First Quarter 2022 Financial Results [May-03-22 04:05PM] Veracyte (VCYT) Reports Q1 Loss, Tops Revenue Estimates [May-03-22 06:15PM] Veracyte Announces New Consensus Data from PROCURE Study Presented at ESMO Breast Cancer 2022 [May-04-22 08:30AM]
28-02-2022	AH	4:05 PM ET (Feb 28)	VCYT	Veracyte, Inc.	1,860	-0.15	-0.14	-0.14	Veracyte GAAP EPS of -$0.15 beats by $0.04, revenue of $67.3M beats by $4.57M [2/28/2022 4:14 PM]	27.93	0.13 (0.47%)	27.80	0.0 (0.00%)	22.00 - 64.83	1,029,254	740,000	13,110
Veracyte GAAP EPS of -$0.15 beats by $0.04, revenue of $67.3M beats by $4.57M [2/28/2022 4:14 PM] Veracyte Appoints Annie McGuire as General Counsel [Feb-28-22 08:30AM] Veracyte Announces Fourth Quarter and Full-Year 2021 Financial Results [Feb-28-22 04:05PM] Veracyte (VCYT) Reports Q4 Loss, Tops Revenue Estimates [Feb-28-22 06:25PM] Veracyte to Participate in the Cowen 42nd Annual Health Care Conference [Mar-01-22 04:05PM]
09-11-2021	AH	4:05 PM ET (Nov 9)	VCYT	Veracyte, Inc.	3,720	-0.13	-0.14	-0.08	Veracyte EPS misses by $0.03, beats on revenue [11/9/2021 4:26 PM]	46.05	-4.04 (-8.07%)	50.09	0.0 (0.00%)	32.87 - 86.03	675,735	500,000	5,330
Veracyte EPS misses by $0.03, beats on revenue [11/9/2021 4:26 PM] Veracyte Announces Third Quarter 2021 Financial Results [Nov-09-21 04:05PM] Veracyte (VCYT) Reports Q3 Loss, Tops Revenue Estimates [Nov-09-21 07:05PM]
29-07-2021	AH	4:05 PM ET (Jul 29)	VCYT	Veracyte, Inc.	2,640	-0.13	-0.25	-0.22	Veracyte EPS beats by $0.13, beats on revenue [7/29/2021 4:13 PM]	44.54	5.31 (13.54%)	41.00	1.77 (4.51%)	28.82 - 86.03	1,133,964	560,000	9,191
Veracyte EPS beats by $0.13, beats on revenue [7/29/2021 4:13 PM] ERYTECH Pharma, Allied Healthcare Products leads healthcare gainers; Intec Pharma, Translate Bio among major losers [7/30/2021 11:00 AM] After Naming a New CFO, Is This Genetic Diagnostics Company a Buy? [Jul-29-21 06:55AM] Veracyte Announces Second Quarter 2021 Financial Results [Jul-29-21 04:05PM] Veracyte (VCYT) Reports Q2 Loss, Tops Revenue Estimates [Jul-29-21 06:45PM]
10-05-2021	AH	4:05 PM ET (May 10)	VCYT	Veracyte, Inc.	3,090	-0.11	-0.12	-0.24	Veracyte EPS misses by $0.55, beats on revenue [5/10/2021 4:13 PM]	39.91	-2.40 (-5.67%)	39.51	-2.80 (-6.62%)	22.69 - 86.03	1,707,978	660,000	2,020
Veracyte EPS misses by $0.55, beats on revenue [5/10/2021 4:13 PM] Veracyte names Marc Stapley CEO [5/10/2021 4:26 PM] Veracyte, Inc. to Host Earnings Call [May-10-21 02:30PM] Veracyte, Inc. Announces CEO Succession Plan [May-10-21 04:10PM] Veracyte Announces First Quarter 2021 Financial Results [May-10-21 04:05PM] Veracyte (VCYT) Reports Q1 Loss, Tops Revenue Estimates [May-10-21 06:50PM]
17-02-2021	AH	4:05 PM ET (Feb 17)	VCYT	Veracyte, Inc.	5,030	-0.14	-0.09	-0.15	Veracyte EPS misses by $0.02, beats on revenue [2/17/2021 4:30 PM]	69.82	-4.18 (-5.65%)	74.00	0.0 (0.00%)	13.90 - 86.03	1,011,323	1,463,798	17,134
Veracyte EPS misses by $0.02, beats on revenue [2/17/2021 4:30 PM] Veracyte: Q4 Earnings Insights [Feb-17-21 04:25PM] Veracyte Announces Fourth Quarter and Full-Year 2020 Financial Results [Feb-17-21 04:05PM] Veracyte, Inc. to Host Earnings Call [Feb-17-21 02:30PM]
02-11-2020	AH	4:05 PM ET (Nov 2)	VCYT	Veracyte, Inc.	2,120	-0.08	-0.18	-0.02	Veracyte EPS beats by $0.12, beats on revenue [11/2/2020 4:33 PM]	38.40	3.40 (9.71%)	34.03	-0.97 (-2.77%)	13.90 - 44.64	677,078	491,517	13,766

30-07-2020	AH	4:05 PM ET (Jul 30)	VCYT	Veracyte, Inc.	1,420	-0.22	-0.22	-0.05	Veracyte EPS beats by $0.05, beats on revenue [7/30/2020 4:15 PM]	36.04	2.83 (8.52%)	33.40	0.19 (0.57%)	13.90 - 36.20	649,923	501,300	19,893

06-05-2020	AH		VCYT	Veracyte, Inc.	1,370	-0.24	-0.18	-0.05		0.0	0.0 (0.00%)	0.0	0.0 (0.00%)	0.0 - 0.0	0	0	0